- Home
- SIBN vs VALN Comparison
SIBN vs VALN Comparison
Compare SIBN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- VALN
- Stock Information
- Founded
- SIBN 2008
- VALN 2012
- Country
- SIBN United States
- VALN France
- Employees
- SIBN N/A
- VALN N/A
- Industry
- SIBN Medical/Dental Instruments
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIBN Health Care
- VALN Health Care
- Exchange
- SIBN Nasdaq
- VALN Nasdaq
- Market Cap
- SIBN 571.0M
- VALN 510.7M
- IPO Year
- SIBN 2018
- VALN 2021
- Fundamental
- Price
- SIBN $18.32
- VALN $6.36
- Analyst Decision
- SIBN Strong Buy
- VALN Strong Buy
- Analyst Count
- SIBN 5
- VALN 3
- Target Price
- SIBN $24.40
- VALN $15.33
- AVG Volume (30 Days)
- SIBN 446.0K
- VALN 15.0K
- Earning Date
- SIBN 05-05-2025
- VALN 05-07-2025
- Dividend Yield
- SIBN N/A
- VALN N/A
- EPS Growth
- SIBN N/A
- VALN N/A
- EPS
- SIBN N/A
- VALN N/A
- Revenue
- SIBN $176,601,000.00
- VALN $201,099,222.00
- Revenue This Year
- SIBN $18.52
- VALN $17.98
- Revenue Next Year
- SIBN $16.39
- VALN $26.61
- P/E Ratio
- SIBN N/A
- VALN N/A
- Revenue Growth
- SIBN 22.60
- VALN 21.64
- 52 Week Low
- SIBN $11.70
- VALN $3.62
- 52 Week High
- SIBN $19.16
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- SIBN 77.73
- VALN 46.37
- Support Level
- SIBN $13.64
- VALN $6.25
- Resistance Level
- SIBN $18.91
- VALN $6.65
- Average True Range (ATR)
- SIBN 0.75
- VALN 0.30
- MACD
- SIBN 0.58
- VALN -0.02
- Stochastic Oscillator
- SIBN 90.04
- VALN 27.24
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.